Thrombolytic therapy during or after cardiopulmonary resuscitation. Efficacy and safety of a new therapeutic approach

Minerva Anestesiologica

Volumn 69, Issue 5, 2003, Pages 357-364

  Spohr F ^a   Bottiger B W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiopulmonary resuscitation; Hemorrhage; Myocardial infarction; Pulmonary embolism; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; LUNG EMBOLISM; MICROCIRCULATION; OUTCOMES RESEARCH; PROGNOSIS; REPERFUSION; RESUSCITATION; REVIEW; SAFETY; TREATMENT OUTCOME; CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; HEART INFARCTION;

CARDIOPULMONARY RESUSCITATION; CLINICAL TRIALS; EMERGENCY MEDICAL SERVICES; HUMANS; MYOCARDIAL INFARCTION; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY;

EID: 0141613091     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Bode C, Nordt TK, Runge MS. Thrombolytic therapy in acute myocardial infarction-selected recent developments. Ann Hematol 1994;69:S35-40.
2. Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999;115:1695-707.
3. Curzen N, Haque R, Timmis A. Applications of thrombolytic therapy. Intensive Care Med 1998;24:756-68.
4. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100:1016-30.
5. Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 1996;17:43-63.
6. Silfvast T. Cause of death in unsuccessful prehospital resuscitation. J Intern Med 1991;229:331-5.
7. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629-33.
8. Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
9. The Hypothermia after Cardic Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56.
10. Böttiger BW, Spöhr F. The risk of thrombolysis in association with cardiopulmonary resuscitation: no reason to withhold this causal and effective therapy. J Intern Med 2003;253:99-101.
11. Padosch SA, Motsch J, Böttiger BW. Thrombolysis during cardiopulmonary resuscitation. Anaesthesist 2002;51:516-32.
12. Hossmann KA. Ischemia-mediated neuronal injury. Resuscitation 1993;26:225-35.
13. Safar P, Stezoski W, Nemoto EM. Amelioration of brain damage after 12 minutes' cardiac arrest in dogs. Arch Neurol 1976;33;91-5.
14. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 1996;22:1214-23.
15. Böttiger BW. Thrombolysis during cardiopulmonary resuscitation. Fibrinolysis 1997;(Suppl 2):93-100.
16. Böttiger BW, Motsch J, Böhrer H, Böker T, Aulmann M, Nawroth PP, et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995;92:2572-8.
17. Böttiger BW, Bohrer H, Bach A, Motsch J, Martin E. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 1994;28:45-54.
18. Newman DH, Greenwald I, Callaway CW. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 2000;35:472-80.
19. Böttiger BW, Bode C, Kern S, Gries A, Gust R, Glätzer R, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001;357:1583-5.
20. Jäger D, Machraoui A, Melz F, Scholz-Jager A, Straub H, Barmeyer J. Systemic fibrinolysis following resuscitation or temporary electrostimulation. Dtsch Med Wochenschr 1990;115:1009-13.
21. Scholz KH, Hilmer T, Schuster S, Wojcik J, Kreuzer H, Tebbe U. Thrombolysis in resuscitated patients with pulmonary embolism. Dtsch Med Wochenschr 1990;115:930-5.
22. Cross SJ, Lee HS, Rawles JM, Jennings K. Safety of thrombolysis in association with cardiopulmonary resuscitation. Bmj 1991;303:1242.
23. Scholz KH, Tebbe U, Herrmann C, Wojcik J, Lingen R, Chemnitius JM, et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol 1992;69:724-8.
24. van Campen LC, van Leeuwen GR, Verbeugt FW. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 1994;73:953-5.
25. Ruiz-Bailén M, Aguayo de Hoyos E, Serrano-Córcoles MC, Díaz-Castellanos MA, Ramos-Cuadra JA, Reina-Toral A. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med 2001;27:1050-7.
26. Voipio V, Kuisma M, Alaspaa A, Manttari M, Rosenberg P. Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest. Resuscitation 2001;49:251-8.
27. Kürkciyan I, Meron G, Sterz F, Mullner M, Tobler K, Domanovits H, et al. Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment. J Intern Med 2003;253:128-35.
28. Tenaglia AN, Califf RM, Candela RJ, Kereiakes DJ, Berrios E, Young SY, Stack RS, Topol EJ. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cardiol 1991;68:1015-9.
29. Bedell SE, Delbanco TL, Cook EF, Epstein FH. Survival after cardiopulmonary resuscitation in the hospital. N Engl J Med 1983;309:569-70.
30. Ballew KA, Philbrick JT, Caven DE, Schorling JB. Predictors of survival following in-hospital cardiopulmonary resuscitation. A moving target. Arch Intern Med 1994;154:2426-32.
31. Schreiber W, Gabriel D, Sterz F, Muellner M, Kuerkciyan I, Holzer M, et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation 2002;52:63-9.
32. Renkes-Hegendörfer U, Herrmann K. Successful treatment of a case of fulminant massive pulmonary embolism with streptokinase. Anaesthesist 1974;23:500-1.
33. Böttiger BW, Martin E. Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest. Curr Opin Crit Care 2001;7:176-83.
34. Köhle W, Pindur G, Stauch M, Rasche H. Hochdosierte Streptokinasetherapie bei fulminanter Lungenarterienembolie. Anaesthesist 1984;33:469.
35. Gramann J, Lange-Braun P, Bodemann T, Hochrein H. Der Einsatz von Thrombolytika in der Reanimation als Ultima ratio zur Überwindung des Herztodes. Intensiv- und Notfallbehandlung 1991;16:134-7.
36. Kürkciyan I, Meron G, Sterz F, Janata K, Domanovits H, Holzer M, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000;160:1529-35.
37. Klefisch F, Gareis R, Störk T, Möckel M, Danne O. Präklinische ultima-ratio Thrombolyse bei therapierefraktärer kardiopulmonaler Reanimation. Intensivmedizin 1995;32:155-62.
38. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71-6.
39. Abu-Laban RB, Christenson JM, Innes GD, van Beek CA, Wanger KP, McKnight RD, et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 2002;346:1522-8.
40. Bedell SE, Fulton EJ. Unexpected findings and complications at autopsy after cardiopulmonary resuscitation (CPR). Arch Intern Med 1986;146:1725-8.
41. Böttiger BW, Padosch SA, Wenzel V, Paradis NA, Knaut A, Halperin H, et al. Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity. N Engl J Med 2002;17:1281-2.
42. Califf RM, Fortin DF, Tenaglia AN, Sane DC. Clinical Risks of Thrombolytic Therapy. Am J Cardiol 1992;69:12A-20A.
43. Spöhr F, Böttiger BW. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Saf 2003; in press.
44. Nagel EL, Fine EG, Krischer JP, Davis JH. Complications of CPR. Crit Care Med 1981;9:424.
45. Powner DJ, Holcombe PA, Mello LA. Cardiopulmonary resuscitation-related injuries. Crit Care Med 1984;12:54-5.
46. Krischer JP, Fine EG, Davis JH, Nagel EL. Complications of cardiac resuscitation. Chest 1987;92:287-91.
47. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343:311-22.
48. Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest 1997;111:1241-5.